NCT02666066View on ClinicalTrials.gov

Radiomics for Prediction of Survival in GBM

CompletedOBSERVATIONAL
Enrollment

289

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

July 31, 2018

Conditions
GlioblastomaGliomaAstrocytoma
Trial Locations (1)

6229ET

Maastricht Radiation Oncology (MAASTRO clinic), Maastricht

All Listed Sponsors
lead

Maastricht Radiation Oncology

OTHER

NCT02666066 - Radiomics for Prediction of Survival in GBM | Biotech Hunter | Biotech Hunter